HYBRID EVENT: You can participate in person at Baltimore, Maryland, USA or Virtually from your home or work.
Yihua Zhong, Speaker at Oncology Conferences
Department of Gastroenterology, Chongqing University Cancer Hospital, Chongqing, China, China


Gastrointestinal metastases of lung cancer are relatively uncommon, yet occur at a higher frequency than would be expected among patients that exhibit a longer survival interval. Metastases that arise in the small intestines are often associated with no or few symptoms such that their early diagnosis can be challenging. In this report, we describe an extremely rare case of a lung squamous cell carcinoma that had metastasized to the small intestine and was associated with symptoms of abdominal pain. The patient underwent capsule endoscopy which detected an irregular mass in the distal ileum that was hemorrhagic, after which laparoscopic ileal resection and anastomosis in parallel with partial bladder resection were performed. Subsequent pathological biopsy confirmed that the intestinal mass was consistent with metastatic squamous cell carcinoma. With surgery and subsequent maintenance therapy with targeted drugs, the survival of the patient was more than 6 months. As a noninvasive testing strategy, capsule endoscopy can be easily performed to support etiological diagnostic efforts in cases where other diagnostic options are lacking. Early diagnosis and therapeutic intervention can contribute to better prognostic outcomes for GMLC patients.

Audience Take Away Notes:

• Advanced age, parenteral metastasis and intestinal perforation were negative prognostic factors for GMLC, while abdominal surgery was positive prognostic factors
• Small intestine metastasis is the most common site of GMLC. As a non-invasive test, SBCE is recommended as a first-line test for rapid and detailed etiological diagnosis
• After MDT discussion, adequate and careful evaluation, targeted surgery and systematic treatment of specific patients can improve GMLC patients survival and quality of life


Dr. Zhong graduated from Chongqing Medical University, majoring in Clinical Medicine, and received her postgraduate degree in 2011. He has been engaged in clinical work on gastrointestinal tumors for a long time. In 2013, he was awarded the position of deputy chief physician. He is currently the deputy head of capsule endoscopy of Chongqing Digestive Committee and a member of other professional committees. He has written more than 10 SCI, CSCD and other papers.